J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...

Johnson & Johnson announced the submission of regulatory applications to the U.S. FDA and European Medicines Agency seeking approval of a ...

(RTTNews) - Johnson & Johnson (JNJ), Friday announced the submission of regulatory applications for Darzalex Faspro to the U.S. Food and Drug Administration, and Darzalex to the European Medicines ...

And there are lingering concerns about the possible (albeit extremely low) risk of thyroid cancer from taking Ozempic, ...

Hungary's Olivér Várhelyi will have to explain to Members of the European Parliament exactly how he will promote women’s ...

Plants and their essential oils to help prevent or tackle coughs and colds Dr Aslam said: “Echinacea has long been used to ...

Leqembi is approved for Alzheimer’s patients in multiple territories, but questions remain over its cost-effectiveness.

RP-L102, which the firm designed to treat a form of disease caused by FANCA mutations, is already under review with the European Medicines Agency.

The European Medicine Agency continues to review the KOSTAIVE marketing authorization ... individuals with CF who do not qualify for or benefit from CFTR modulator medicines due to dysfunctional or ...

The CDC is urging workers to wear personal protective equipment during what the agency views as high-risk activities ... If finalized, the move could reshape the market for over-the-counter cold ...

The agency reviewed data from the FELIX trial, in which 63 percent of patients achieved a complete remission on the cell therapy at any time point.